Head and neck paragangliomas: Report of 175 patients (1989-2010)

Head and Neck

Volumn 34, Issue 5, 2012, Pages 632-637

  Papaspyrou, Konstantinos ^a   Mewes, Torsten ^a   Rossmann, Heidi ^a   Fottner, Christian ^a   Schneider Raetzke, Brigitte ^a   Bartsch, Oliver ^a   Schreckenberger, Mathias ^a   Lackner, Karl J ^a   Amedee, Ronald G ^b   Mann, Wolf J ^a  

^a JOHANNES GUTENBERG UNIVERSITY   (Germany)

^b OCHSNER CLINIC FOUNDATION   (United States)

Author keywords

genetic analysis; head and neck; malignancy; paragangliomas; succinate dehydrogenase

Indexed keywords

SUCCINATE DEHYDROGENASE; VON HIPPEL LINDAU PROTEIN;

ARTICLE; CASE STUDY; GENE MUTATION; GENETIC ANALYSIS; HEAD AND NECK CANCER; HETEROZYGOTE; HUMAN; MAJOR CLINICAL STUDY; MALIGNANT NEOPLASTIC DISEASE; MULTIPLE CANCER; PARAGANGLIOMA; PRIORITY JOURNAL; RETROSPECTIVE STUDY; THYROID PAPILLARY CARCINOMA;

CARCINOMA, PAPILLARY; FEMALE; HEAD AND NECK NEOPLASMS; HETEROZYGOTE; HUMANS; MALE; MUTATION; NEOPLASMS, MULTIPLE PRIMARY; PARAGANGLIOMA; RETROSPECTIVE STUDIES; SUCCINATE DEHYDROGENASE; VON HIPPEL-LINDAU TUMOR SUPPRESSOR PROTEIN;

EID: 84859766914     PISSN: 10433074     EISSN: 10970347     Source Type: Journal    
DOI: 10.1002/hed.21790     Document Type: Article

References (26)

1. Milunsky JM, Maher TA, Michels VV, et al. Novel mutations and the emergence of a common mutation in the SDHD gene causing familial paraganglioma. Am J Med Genet 2001; 100: 311-314.
2. Mills SE, Gaffey MJ, Frierson HF Jr,. Tumors of the upper aerodigestive tract and ear. In: Atlas of tumor pathology, series 3, fasc. 26. Washington, DC: Armed Forces Institute of Pathology; 2000.
3. Baysal BE, Farr JE, Rubinstein WS, et al. Fine mapping of an imprinted gene for familial nonchromaffin paragangliomas, on chromosome 11q23. Am J Hum Genet 1997; 60: 121-132.
4. Manolidis S, Shohet JA, Jackson CG, et al. Malignant glomus tumors. Laryngoscope 1999; 109: 30-34.
5. Lee JH, Barich F, Karnell LH, et al. National Cancer Data Base report on malignant paragangliomas of the head and neck. Cancer 2002; 94: 730-737.
6. Baysal BE, Ferrell RE, Willett-Brozick JE, et al. Mutations in SDHD, a mitochondrial complex II gene, in hereditary paraganglioma. Science 2000; 287: 848-851.
7. Niemann S, Müller U,. Mutations in SDHC cause autosomal dominant paraganglioma, type 3. Nat Genet 2000; 26: 268-270.
8. Astuti D, Latif F, Dallol A, et al. Gene mutations in the succinate dehydrogenase subunit SDHB cause susceptibility to familial pheochromocytoma and to familial paraganglioma. Am J Hum Genet 2001; 69: 49-54.
9. Baysal BE,. Hereditary paraganglioma targets diverse paraganglia. J Med Genet 2002; 39: 617-622.
10. Young AL, Baysal BE, Deb A, et al. Familial malignant catecholamine-secreting paraganglioma with prolonged survival associated with mutation in the succinate dehydrogenase B gene. J Clin Endocrinol Metab 2002; 87: 4101-4105.
11. Benn DE, Croxson MS, Tucker K, et al. Novel succinate dehydrogenase subunit B (SDHB) mutations in familial pheochromocytomas and paragangliomas, but an absence of somatic SDHB mutations in sporadic pheochromocytomas. Oncogene 2003; 22: 1358-1364.
12. Gimenez-Roqueplo AP, Favier J, Rustin P, et al. Mutations in the SDHB gene are associated with extra-adrenal and/or malignant pheochromocytomas. Cancer Res 2003; 63: 5615-5621.
13. Cole JM, Beiler D,. Long-term results of treatment of glomus jugulare and glomus vagale tumors with radiotherapy. Laryngoscope 1994; 104: 1461-1465.
14. Foote RL, Pollock BE, Gorman DA, et al. Glomus jugulare tumor: tumor control and complications after stereotactic radiosurgery. Head Neck 2002; 24: 332-338.
15. Renard L, Godfraind C, Boon LM, et al. A novel mutation in the SDHD gene in a family with inherited paragangliomas: implications of genetic diagnosis for follow-up and treatment. Head Neck 2003; 25: 146-151.
16. Papaspyrou K, Rossmann H, Fottner C, et al. Malignant paraganglioma caused by a novel germline mutation of the succinate dehydrogenase D-gene: a case report. Head Neck 2008; 30: 964-969.
17. Pellitteri PK, Rinaldo A, Myssiorek D, et al. Paragangliomas of the head and neck. Oral Oncol 2004; 40: 563-575.
18. Kollert M, Minovi AA, Draf W, et al. Cervical paragangliomas: tumor control and long-term functional results after surgery. Skull Base 2006; 16: 185-191.
19. Neumann HPH, Pawlu C, Peczkowska M, et al. Distinct clinical features of paraganglioma syndromes associated with SDHB and SDHD gene mutations. J Am Med Assoc 2004; 292: 943-951.
20. Papaspyrou K, Mann WJ, Amedee RG,. Management of head and neck paragangliomas: review of 120 individuals. Head Neck 2009; 31: 381-387.
21. Benn DE, Gimenez-Roqueplo AP, Reilly JR, et al. Clinical presentation and penetrance of pheochromocytoma/paraganglioma syndromes. J Clin Endocrinol Metab 2006; 91: 827-836.
22. 18F-DOPA positron emission tomography for the detection of glomus tumours. Eur J Nucl Med Mol Imaging 2003; 30: 689-694.
23. Amar L, Bertherat J, Baudin E, et al. Genetic testing in pheochromocytoma or functional paraganglioma. J Clin Oncol 2005; 23: 8812-8818.
24. Astrom K, Cohen JE, Willett-Brozick JE, et al. Altitude is a phenotypic modifier in hereditary paraganglioma type 1: evidence for an oxygen-sensing defect. Hum Genet 2003; 113: 228-237.
25. Havekes B, Corssmit EP, Jansen JC, et al. Malignant paragangliomas associated with mutations in the succinate dehydrogenase D gene. J Clin Endocrinol Metab 2007; 92: 1245-1248.
26. Neumann HP, Erlic Z, Boedeker CC, et al. Clinical predictors for germline mutations in head and neck paraganglioma patients: cost reduction strategy in genetic diagnostic process as fall-out. Cancer Res 2009; 69: 3650-3656.